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Abstract
Background: It is useful to predict planned dosimetry and determine the eligibility of a liver cancer patient for
SBRT treatment using knowledge based planning (KBP). We compare the predictive accuracy using the overlap
volume histogram (OVH) and statistical voxel dose learning (SVDL) KBP prediction models for coplanar VMAT to
non-coplanar 4π radiotherapy plans.
Methods: In this study, 21 liver SBRT cases were selected, which were initially treated using coplanar VMAT plans.
They were then re-planned using 4π IMRT plans with 20 inversely optimized non-coplanar beams. OVH was calculated by
expanding the planning target volume (PTV) and then plotting the percent overlap volume v with the liver vs. rv, the
expansion distance. SVDL calculated the distance to the PTV for all liver voxels and bins the voxels of the same distance.
Their dose information is approximated by either taking the median or using a skew-normal or non-parametric fit, which
was then applied to voxels of unknown dose for each patient in a leave-one-out test. The liver volume receiving less than
15 Gy (V<15Gy), DVHs, and 3D dose distributions were predicted and compared between the prediction models and
planning methods.
Results: On average, V<15Gy was predicted within 5%. SVDL was more accurate than OVH and able to predict DVH and
3D dose distributions. Median SVDL yielded predictive errors similar or lower than the fitting methods and is
more computationally efficient. Prediction of the 4π dose was more accurate compared to VMAT for all prediction
methods, with significant (p < 0.05) results except for OVH predicting liver V<15Gy (p = 0.063).
Conclusions: In addition to evaluating plan quality, KBP is useful to automatically determine the patient eligibility for
liver SBRT and quantify the dosimetric gains from non-coplanar 4π plans. The two here analyzed dose prediction
methods performed more accurately for the 4π plans than VMAT.
Introduction
Stereotactic Body Radiation Therapy (SBRT) has emerged
as a promising treatment modality for hepatocellular
carcinoma (HCC), liver oligometastatic disease and other
liver tumors when patients are contraindicated for surgical
resection [1, 2]. Compared to conventionally fractionated
radiotherapy, the hypofractionated SBRT treatment, deliv-
ered in 3–5 fractions, is more biologically effective to
achieve improved local control rates [2–4]. Brown et al.
[5] attributed the success of SBRT to dose escalation
enabled by improved dose conformality and delivery ac-
curacy using modern planning and delivery techniques,
including intensity modulated radiotherapy (IMRT) and
image guided radiation therapy. It has been recently
shown that by automatically selecting and optimizing
non-coplanar beams in the 4π planning method, the dose
conformality can be further improved to spare a larger
volume of normal tissue from high dose irradiation [6, 7].
However, the dosimetric improvement may come at a cost
of substantially prolonged treatment time due to the time
to set up the number of non-coplanar couch angles. On
the other hand, even with these technological advances,
the patient eligibility for a specific treatment method due
to critical organ tolerance to the aggressive dose fraction-
ations is unclear. The liver volume doses, among other
metrics, have been shown to correlate with radiation-
induced liver disease [8, 9].
In an earlier study to provide guidelines to treatment
planning, a predictive model was developed to calculate the
maximum tolerable dose for Helical TomoTherapy-based
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SBRT [10]. The model provided a crude estimate for the
achievable target dose based on the liver and PTV volume
but it did not consider the relative position of the PTV to
the liver and was unable to predict the liver dose volume
for a given prescription. In practice, a trial and error plan-
ning process is adopted to determine the level of normal
organ doses and patient eligibility but the result can be op-
erator and planning method dependent. As a result,
potentially eligible patients may be turned down for SBRT
or treated to a reduced and less effective dose [11]. A re-
cently developed paradigm referred to as knowledge based
planning (KBP) may be helpful to improve the process.
KBP was developed to address the challenge that even
with the guidance of published protocols, the planning
goals for an individual patient are unclear. This ambiguity
may lead to either wasted planning time on plans that
cannot be further improved or stopping prematurely when
a better plan quality can be attained [12–15]. KBP attempts
to overcome this challenge by developing geometric and
dosimetric associations with previously treated patients and
using these associations to predict the dosimetry of a new
patient. There have been numerous studies using KBP to
identify suboptimal plans with unnecessary dose to critical
structures [12–17]. Specifically for fractionated liver radio-
therapy, a commercial KBP tool has been used to automat-
ically create planning objectives that resulted in clinically
acceptable plans [18].
In the current study, we aim to answer a different set
of questions for the liver SBRT planning regarding the
accuracy of two popular KBP methods to predict coplanar
VMAT and non-coplanar 4π radiotherapy plan dosimetry.
Answering these questions will elucidate not only the pre-
dictability of the two different planning methods, without
going through the lengthy planning process, but also the
potential gains of using the time consuming 4π radiother-
apy for specific patients.
Methods and materials
Patients and volumetric modulated arc therapy (VMAT)
planning
Twenty-one consecutive liver SBRT patients were selected
with prescription doses ranging from 30 to 60 Gy in five
fractions. Liver volumes ranged from 550 to 3346 cc and
PTV volumes from 2 to 222 cc. The patient cohort includes
a pediatric patient with a small liver volume and a patient
with enlarged liver due to cancer infiltration. The patients
were clinically treated using VMAT (RapidArc, Eclipse
Treatment Planning System version 10, Varian) with either
2 coplanar full arcs or 2–3 coplanar partial arcs entering
the body proximal to the tumor, depending on the tumor
laterality. The VMAT optimization and dose calculation in
Eclipse used the Progressive Resolution Optimizer (PRO,
version 10.0.28) and anisotropic analytical algorithm
(AAA, version 10.0.28) with 2.5x2.5x2.5 mm3 grid
resolution, respectively. Collimator rotations were used
between arcs. All plans were normalized to cover 95%
of the PTV by the prescription dose. For the OARs,
plan objectives are liver volume receiving less than
15 Gy > 700 cc, stomach and bowel volumes receiving
more than 20 Gy < 20 cc, maximal dose to kidney and
spinal cord <12Gy. The same objectives were applied to
all prescription doses.
4π radiotherapy
The 21 liver patients were re-planned using 4π radio-
therapy [6, 7]. 4π radiotherapy utilizes a candidate pool
of 1162 non-coplanar beams evenly distributed 6° apart
throughout the 4π steradian solid angle space. The treat-
ment geometry was predicted based on a computer
assisted design (CAD) model of a Varian TrueBeam
machine and a 3D scan (Artec 3D camera) of a human
subject [19]. Beams resulting in collision between the
gantry and couch or patient were eliminated. An in-
house greedy column generation algorithm was used to
iteratively select and optimize 20 non-coplanar beams
from the candidate pool [20, 21]. The column generation
process chooses each optimal beam one at a time and
performs fluence map optimization after every beam,
which is necessary to choose the subsequent optimal
beam. The gantry and couch angles for the 20 4π beams
were then imported into Eclipse to reoptimize the flu-
ence maps and calculate the final IMRT dose using Dose
Volume Optimizer (DVO, version 10.0.28) and AAA al-
gorithms. The dose calculation algorithms and parame-
ters are identical to those used in VMAT plans, allowing
unbiased comparison between the clinically feasible 4π
and the VMAT plans. When the 4π beam angles were
imported into the Eclipse planning system, they were
converted from the patient centered steradian angles to
gantry and couch angles.
Predicting liver dose distribution using KBP
Based on a multi-institutional phase I/II liver SBRT trial,
the liver volume receiving 15 Gy or less was used as the
eligibility criterion for SBRT treatment [4]. A minimum
of 700 cc liver tissue should be spared from 15 Gy. The
criterion was derived based on surgical and conventional
fractionated radiation therapy experience and confirmed
by subsequent clinical trials [4]. The patient with small
liver volume was an exception that did not meet the cri-
terion. However, this did not influence our study pre-
dicting the liver V<15Gy. Two methods, overlap volume
histogram (OVH) [16] and statistical voxel dose learning
[13] were adapted to establish the correlation between
patient geometry and dose. Both KBP methods used the
OAR and dose data at 2.5x2.5x2.5 mm3 resolution. The
various KBP methods and their prediction capabilities
are summarized in Table 1 and described in the following
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text. All KBP methods were used to predict both VMAT
and 4π dose.
Predicting liver dose volume values using OVH
The OVH is defined, as described by Wu et al. [16, 22],
as the fractional volume of the OAR volume (VO) within
distance r of the target (T)
OVH rð Þ ¼ p∈VOjd p;Tð Þ≤rf g
VO
where d(p,T) is the signed distance between point p and
the target boundary such that d is negative within the
target and positive outside. This is physically equivalent
to isotropically expanding the target by r cm and calcu-
lating the fractional volume of the OAR that overlaps
with the expanded target. When the OAR overlaps with
the PTV, the target needs to be contracted until there is
no overlap to obtain the complete OVH.
A single point from the OVH: rv, the expansion distance
to overlap fractional volume v, was used to quantify the
relationship between the OVH and the liver volume re-
ceiving less than 15 Gy, denoted by V<15Gy [16]. The cor-
relation coefficients of various rv values with liver V<15Gy
were evaluated, including v = 5, 10, 15, 20, and 30%. Linear
regression was used to calculate and predict the liver
V<15Gy from the r10 of an unplanned patient.
Predicting liver dose using statistical voxel dose learning
(SVDL)
The minimal Euclidean distance from each OAR voxel
to the target is defined as
m p;Tð Þ ¼ min
t ∈ T
p−tj j
where p ∈ VO and T is the subset of target boundary
voxels. The voxels were sorted into bins based on their
distance to the target. There will then be a resulting
histogram of doses received by voxels of the same distance
bin. SVDL is the method of utilizing this distance-dose
information to predict dose.
To approximate the dose distribution of each distance
bin and then apply the result to liver voxels of a patient
with unknown dose, three sub-approaches were tested.
First, a single median value was used to represent the
distribution. The distribution mean and mode were also
tested using this method, but were not found to be as
accurate as using the median to approximate the distribu-
tion. The approach clearly loses information but can assign
a single dose value to each voxel of a new patient, allowing
it to predict liver V<15Gy, DVH, and 3D dose. Second, to
capture more statistical information from the distribution,
two algorithms were applied to correct the bias in the raw
data sampling due to fewer available points for voxels at a
shorter distance to the PTV. A skew-normal distribution
was used to fit the raw distribution as described by
Appenzoller et al. [13]. Alternatively, the distribution
was resampled by convolution with a Gaussian kernel
so that each distance bin was represented by an equal
number of 10,000 data points.
Evaluating prediction accuracy
The performance of OVH and SVDL in predicting liver
V<15Gy, DVH, and 3D dose was evaluated and compared
using a leave one out cross validation (LOOCV) test. For
each patient, it is “left out” of the training set, which is
then used to predict the patient’s dose using either OVH
or SVDL. V<15Gy prediction error was evaluated as the
percent error defined as:
Percent error ¼ Actual−Predictedj j
Actual
 100:
Additionally, for the SVDL method, prediction of the
entire liver DVH was evaluated using the residual sum
of squares (RSS), which is defined as
RSSDVH ¼
X∞
D¼0
DVHactual Dð Þ− DVHpredicted Dð Þ
 
⋅ ΔD
 2
:
Low RSS values indicate good agreement between the
actual and predicted DVH throughout the whole DVH.
Likewise, the residual can be used to evaluate the pre-
dictive accuracy of the 3D dose distribution, normalized
to the number of voxels making the mean squared error
(MSE), for the single value SVDL prediction method,
MSED ¼
Xn
i ¼1 Di;actual− Di;predicted
 2
n
:
where n is the number of voxels in the OAR.
Because of the narrower 4π dose-distance spread, a
paired one-tailed t-test was performed to compare the
prediction error of VMAT and 4π plans. Results were
considered significant if p < 0.05. Calculations were
Table 1 Summary of KBP methods and prediction capabilities
Treatment planning
method
OVH SVDL
Median Non-parametric Skew-normal
4π V<15Gy V<15Gy, DVH, 3D dose V<15Gy, DVH V<15Gy, DVH
VMAT V<15Gy V<15Gy, DVH, 3D dose V<15Gy, DVH V<15Gy, DVH
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performed using MATLAB (version R2015a, MathWorks)
on a PC with two Intel Xeon E5 processors at 3.10 GHz.
Results
OVH
Figure 1a shows the liver OVH of all 21 patients for 4π
and VMAT plans and Fig. 1b shows the correlation
between r10 and the liver volume receiving less than
15 Gy. r10 showed the best correlation, with correlation
coefficients of 0.897 and 0.815 for 4π and VMAT liver
V<15Gy, respectively, and was used for subsequent ana-
lysis. Using a least-squares linear fit, the normalized liver
V<15Gy is correlated with r10 by:
V 4π<15Gy ¼ 14:2r10 þ 71:8
VVMAT<15Gy ¼ 15:0r10 þ 67:1
for the 4π and VMAT plans, respectively. The results
suggest that on average, 4π therapy increased liver
V<15Gy by 4.7%, corresponding to an average volume in-
crease of 78.9 cc, which shows an improvement in the
4π planning technique compared to the previous publi-
cation [6]. The percent error in the LOOCV test
predicting the liver V<15Gy using OVH r10 is shown on
the two leftmost columns of Fig. 3a) as a boxplot of the
results from the 21 patients.
SVDL
Figure 2a, b shows a scatter plot of the distance to the
target vs. dose received for every liver voxel from the pa-
tient cohort for 4π plans and VMAT plans. Each column
of data points represents the data within each distance
bin. The percent error in predicting the liver V<15Gy of
the patient cohort is presented in Fig. 3a, with 4π and
VMAT represented in blue and red, respectively. Com-
pared to SVDL, OVH resulted in the worst V<15Gy pre-
diction performance for 4π with an average percent
error of 3.76%, compared to 2.58 2.97% for the SVDL
prediction methods. OVH also resulted in an average
percent error of 5.33% for VMAT, which is superior to
SVDL using non-parametric fitting but inferior to other
SVDL methods.
Boxplots of the RSSDVH for the patients are shown in
Fig. 3b. The actual and predicted DVHs along with their
corresponding residuals for three distinctive cases are
shown in Figs. 4 and 5, for 4π and VMAT plans re-
spectively. Here, the predicted DVHs for all SVDL
Fig. 1 a OVH for all 20 patients. b Expansion distance at 10% OVH vs. percentage of liver receiving less than 15 Gy
Tran et al. Radiation Oncology  (2017) 12:70 Page 4 of 9
methods – median approximation, non-parametric, and
skew-normal fitting prediction – are shown. The first
example (top rows) shows a DVH that was accurately
predicted by most prediction methods, so its corre-
sponding residual is close to zero. The second (middle
rows) and third (bottom rows) examples are DVHs that
were under- or over-predicted.
The SVDL method using the median of each distance
bin to predict the liver V<15Gy resulted in the lowest
average prediction error for both 4π and VMAT plans.
The non-parametric and skew-normal fitting methods
did not improve the liver V<15Gy prediction despite more
statistical information being retained. In contrast, although
the median SVDL proved to be better at predicting V<15Gy,
the SVDL methods retaining more statistical information
were better at predicting DVHs. In this case, as shown in
Fig. 3b, the non-parametric fitting SVDL method attained
the lowest average RSSDVH for both 4π and VMAT plans,
followed by the skew-normal and median SVDL methods.
In other words, keeping the statistical information has a
slight benefit in predicting the DVH.
In addition to the differences in performance resulting
from using two different KBP methods, another important
finding is the predictability of the VMAT and the non-
coplanar 4π plans. The V<15Gy prediction accuracy of 4π
plans was consistently superior to the VMAT plans using
all prediction methods. The differences in V<15Gy predic-
tion error were statistically significant between 4π and
Fig. 2 Distance to the target vs. dose received at every liver voxel
for a 4π and b VMAT plans
Fig. 3 Boxplot results for the leave-one-out cross validation tests for the 21 patient cohort, where median, non-parametric, and skew-normal are
the SVDL methods. For each box, the central mark represents the median and the edges the 25th and 75th percentiles. Whiskers cover the
remaining data not deemed outliers, *p < 0.05. a Percent error in predicting the liver V < 15Gy using OVH and SVDL for 4π and VMAT
plans. b Residual sum of squares analysis using SVDL to predict 4π and VMAT DVHs. c Residual sum of squares analysis for predicting the
3D dose wash using median SVDL prediction for 4π and VMAT
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Fig. 4 a, c, e DVHs and b, d, f residuals of the various SVDL prediction methods for three example 4π cases
Fig. 5 a, c, e DVHs and b, d, f residuals of the various SVDL prediction methods for three example VMAT cases
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VMAT for all prediction methods. The same conclusion
applies to RSSDVH; 4π prediction was shown to be more
accurate than that of VMAT, producing statistically lower
errors for skew-normal SVDL.
The difference in predictability of VMAT and 4π plans
can be intuitively appreciated in Fig. 2 and Fig. 6. Figure 2
shows greater dose spread for voxels at the same distance
to the PTV in the VMAT plans and clear clusters indicating
certain geometrical heterogeneity. Figure 6 shows the
achieved and predicted liver dose for a sagittal slice of an
example patient, using the median SVDL prediction
method for both 4π and VMAT. SVDL predicted a more
isotropic dose distribution that better matched the 4π dose
distribution than that of VMAT, which showed significantly
steeper dose gradient in the superior/inferior direction than
the anterior/posterior and medial/lateral directions. The
difference in prediction accuracy is quantitatively reflected
in the MSED (Fig. 3c). Median SVDL resulted in relatively
low MSED for 4π and VMAT 3D dose prediction. Quanti-
tatively, the 3D dose of the non-coplanar 4π plans were
more accurately predicted than VMAT, attaining significant
results for all applicable prediction methods. The average
4π MSED was less than half of the average VMAT MSED
using the same prediction method.
Total training and prediction times are listed in Table 2.
Calculating OVH for each patient usually takes 1–2 min,
but rv calculation and correlation are fast once OVHs are
calculated for all patients. OVH is considerably faster than
SVDL, which acquires geometric information by calculat-
ing the minimal Euclidean distance to the PTV for every
liver voxel of every patient. This typically takes 1–2 min
depending on the size of the liver. However, unlike OVH
prediction, SVDL requires calculation of the distance bins
taking and additional 1–2 min, which needs to be redone
for every training set. On top of the distance bin
organization, non-parametric and skew-normal SVDL
take significantly longer time to fit each distance bin than
simply taking the median. Once training is finished, liver
dose predictions can be made for any subsequent test pa-
tient as fast as 1 s for OVH and median SVDL or around
5 min for non-parametric and skew-normal fitting SVDL.
Discussion
Several highly relevant questions in liver SBRT are investi-
gated in the study. The first is whether it is feasible to pre-
dict the patient eligibility for SBRT considering the
sensitivity of normal liver tissue to radiation dose. The
second is which of the two available methods is better to
model and predict the liver dose. The third question is
whether the gain in dose compactness by using non-
coplanar radiotherapy is meaningful for a specific patient.
Fig. 6 Actual and predicted dose for a sagittal slice of an example patient using the median SVDL prediction method for 4π and VMAT. While
the actual dose includes dose for the whole body, SVDL only predicts dose within the liver
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To answer these questions, our study employed two
state of the art KBP methods to predict the liver volume
receiving less than 15 Gy as well as the full DVH and
3D dose for coplanar VMAT and non-coplanar 4π radio-
therapy. The study shows that, using the fully automated
methods, the liver V<15Gy can generally be predicted
with errors lower than 5%. Between the two KBP
methods, OVH is less accurate than SVDL but faster be-
cause the OVH curve only needs to be calculated once.
However, the time benefit comes at a cost of limited in-
formation available from OVH. For example, only spe-
cific metrics like V<15Gy can be extracted from OVH
data. By adding 1–2 min per patient for the SVDL
method, the full DVH and 3D dose can be predicted.
Within SVDL, the remarkable performance displayed by
fast median value method relative to the other metrics
makes it the preferred method for quick and accurate
dose prediction.
More interestingly, in addition to quantifying a systematic
advantage, the study reveals a previously unreported
advantage of using optimal non-coplanar geometry for
liver SBRT, which is the superior predictability of the
non-coplanar liver plans using KBP based on Euclidian
distances alone. Both coplanar VMAT and the non-
coplanar 4π plans are independent on the operator to
manually specify the beam orientations, the difference
in prediction accuracy can be intuitively understood by
comparing the isotropicity (Fig. 6).
Previous KBP studies involving coplanar radiotherapy
have either disregarded the anisotropic aspects of the
dose or empirically divided the voxels into in-plane and
out-of-plane voxels based on their relative superior/in-
ferior location to the PTV [23]. However, it is important
to note that there are several pitfalls modifying the dose
prediction methods to include non-isotropicity. First,
because of beam divergence, even without intensity
modulation, VMAT dose distribution cannot be simply
described by a cylinder with defined inferior and super-
ior boundaries. Second, the geometric dose distribution
is further complicated by intensity modulation for indi-
vidual patients. Third, 4π dose distribution is more iso-
tropic than VMAT but still far from a perfect sphere
due to the elongated human body shape and finite num-
ber of non-coplanar beams. In practice, the empirical in-
clusion of beam geometry in the Euclidian distance did
not improve the statistical spread [12]. Since there is no
simple universal way to include this non-isotropicity in
prediction without relying on heuristics that may weaken
the robustness of prediction, we believe the comparison
using simple methods in the study provide is still fair
and informative.
Despite the reduced prediction error for the 4π plans,
there is still a residual statistical spread of voxel doses at
the same distance to PTV, as seen in Fig. 2. It is import-
ant to understand the causes of the remaining uncertain-
ties, as they are partially responsible for residual errors
observed in the downstream liver V<15Gy, DVH and
isodose predictions. The actual dose distribution largely
depends on how the beams are arranged, which being
planning variables are not included as prediction param-
eters. The discretized beams resulted in non-smooth low
dose fall-off that is distinctly different from the smooth
dose fall-off predicted based on Euclidean distances
alone. However, not all discrepancies can or should be
eliminated. Factors including patient, PTV, and liver
sizes, as well as the presence of nearby OARs should be
modeled and separated from the inconsistent plan qual-
ity, which should then be ultimately minimized. While
these factors affect the accuracy of the methods reported
in this study, if they can be incorporated into the KBP
prediction technique, they should help decrease the pre-
diction errors.
An appealing opportunity here is the potential of fully
automating treatment planning. In a commercial treat-
ment planning system, KBP for VMAT has enabled au-
tomated generation of DVH objective points and then
clinically acceptable plans [18]. Similarly, 4π plans have
the potential to be fully automated if the plan quality
can be predicted for a new patient to guide the auto-
mated planning process. We will study the additional
complexity from beam orientation optimization not in
the VMAT planning process.
Conclusion
Two existing KBP methods are used to predict the
liver dose of liver SBRT patients using coplanar VMAT
or non-coplanar 4π planning methods. Between the
two compared KBP methods, SVDL was more accurate
than OVH in all cases. Within SVDL, voxel dose esti-
mated using the computationally inexpensive median
value performed similar to or better than the SVDL
methods retaining the complete statistical information.
The best method depends on the goal of the predic-
tion. For liver SBRT eligibility, our results show that
the liver volume receiving 15 Gy or less can be pre-
dicted within 5%, which is most accurate with median
value based SVDL. We also showed that compared to
the VMAT method, 4π plan dosimetry can be more ac-
curately predicted. Because the improved liver sparing
Table 2 Total training and prediction time per training set
Calculation time per training set
Training time Prediction time
OVH 1–2 min ~1 sec
SVDL Median 2–4 min ~1 sec
Non-parametric ~1 hour ~5 min
Skew-normal ~1 hour ~5 min
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using non-coplanar 4π radiotherapy was also reflected
in the model, KBP provides an individualized predic-
tion of the benefit using the more complex 4π radio-
therapy for liver SBRT. The information can be used to
aid choice of treatment strategies.
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